Risk factors of community-onset urinary tract infections caused by plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae

Journal of Microbiology, Immunology and Infection

Volumn 48, Issue 3, 2015, Pages 269-275

  Lee, Chi Hung ^a,b   Lee, Yi Tzu ^a,b   Kung, Che Hsuan ^a,c   Ku, Wen Wei ^a   Kuo, Shu Chen ^a,b,d   Chen, Te Li ^b   Fung, Chang Phone ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

AmpC lactamase; Community onset; Plasmid mediated; Risk factors; Urinary tract infections

Indexed keywords

BETA LACTAMASE AMPC; CARBAPENEM DERIVATIVE; CEFEPIME; CEPHAMYCIN; EXTENDED SPECTRUM BETA LACTAMASE; PIPERACILLIN; QUINOLONE DERIVATIVE; TAZOBACTAM; AMPC BETA-LACTAMASES; BACTERIAL PROTEIN; BETA LACTAMASE;

AGED; ARTICLE; BACTERIUM ISOLATION; CEREBROVASCULAR ACCIDENT; CITROBACTER; CITROBACTER AMALONATICUS; CITROBACTER FREUNDII; CITROBACTER KOSERI; DEMOGRAPHY; DRUG USE; ENTEROBACTER; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTER GERGOVIAE; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; HUMAN; IN VITRO STUDY; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MORGANELLA MORGANII; MULTIPLEX POLYMERASE CHAIN REACTION; PATIENT IDENTIFICATION; PATIENT RISK; PHENOTYPE; PROTEUS MIRABILIS; PROTEUS PENNERI; PROTEUS VULGARIS; PROVIDENCIA; PROVIDENCIA ALCALIFACIENS; PROVIDENCIA RETTGERI; PROVIDENCIA STUARTII; RISK FACTOR; SERRATIA MARCESCENS; TEACHING HOSPITAL; TERTIARY HEALTH CARE; URINARY TRACT INFECTION; ANALYSIS; COMMUNITY-ACQUIRED INFECTIONS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; PLASMID; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; SECRETION (PROCESS); TAIWAN; TERTIARY CARE CENTER; URINARY TRACT INFECTIONS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BACTERIAL PROTEINS; BETA-LACTAMASES; COMMUNITY-ACQUIRED INFECTIONS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HOSPITALS, TEACHING; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; PLASMIDS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RISK FACTORS; TAIWAN; TERTIARY CARE CENTERS; URINARY TRACT INFECTIONS;

EID: 84929503400     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2013.08.010     Document Type: Article

References (35)

1. Gupta K., Hooton T.M., Stamm W.E. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 2001, 135:41-50.
2. Stamm W.E., Hooton T.M. Management of urinary tract infections in adults. N Engl J Med 1993, 329:1328-1334.
3. Pitout J.D., Nordmann P., Laupland K.B., Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005, 56:52-59.
4. Yang Y.S., Ku C.H., Lin J.C., Shang S.T., Chiu C.H., Yeh K.M., et al. Impact of Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the outcome of community-onset bacteremic urinary tract infections. J Microbiol Immunol Infect 2010, 43:194-199.
5. Jacoby G.A., Munoz-Price L.S. The new beta-lactamases. N Engl J Med 2005, 352:380-391.
6. Lu P.L., Liu Y.C., Toh H.S., Lee Y.L., Liu Y.M., Ho C.M., et al. Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). Int J Antimicrob Agents 2012, (Suppl. 40):S37-S43.
7. Briongos-Figuero L.S., Gomez-Traveso T., Bachiller-Luque P., Dominguez-Gil Gonzalez M., Gomez-Nieto A., Palacios-Martin T., et al. Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing enterobacteria. Int J Clin Pract 2012, 66:891-896.
8. Coudron P.E., Moland E.S., Thomson K.S. Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. J Clin Microbiol 2000, 38:1791-1796.
9. Li Y., Li Q., Du Y., Jiang X., Tang J., Wang J., et al. Prevalence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC beta-lactamase resistance in China. J Clin Microbiol 2008, 46:1317-1321.
10. Song W., Kim J.S., Kim H.S., Yong D., Jeong S.H., Park M.J., et al. Increasing trend in the prevalence of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal ampC gene at a Korean university hospital from 2002 to 2004. Diagn Microbiol Infect Dis 2006, 55:219-224.
11. Denisuik A.J., Lagace-Wiens P.R., Pitout J.D., Mulvey M.R., Simner P.J., Tailor F., et al. Molecular epidemiology of extended-spectrum beta-lactamase-, AmpC beta-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11. J Antimicrob Chemother 2013, 68(Suppl. 1):i57-i65.
12. Philippon A., Arlet G., Jacoby G.A. Plasmid-determined AmpC-type beta-lactamases. Antimicrob Agents Chemother 2002, 46:1-11.
13. Wells W.G., Woods G.L., Jiang Q., Gesser R.M. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy. J Antimicrob Chemother 2004, 53(Suppl. 2):i67-i74.
14. Friedman N.D., Kaye K.S., Stout J.E., McGarry S.A., Trivette S.L., Briggs J.P., et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002, 137:791-797.
15. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. M100-S20 2010, CLSI, Clinical and Laboratory Standards Institute, Wayne, PA.
16. Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement. M100-S19 2009, CLSI, Clinical and Laboratory Standards Institute, Wayne, PA.
17. Doi Y., Paterson D.L. Detection of plasmid-mediated class C beta-lactamases. Int J Infect Dis 2007, 11:191-197.
18. Jeong S.H., Song W., Park M.J., Kim J.S., Kim H.S., Bae I.K., et al. Boronic acid disk tests for identification of extended-spectrum beta-lactamase production in clinical isolates of Enterobacteriaceae producing chromosomal AmpC beta-lactamases. Int J Antimicrob Agents 2008, 31:467-471.
19. Song W., Jeong S.H., Kim J.S., Kim H.S., Shin D.H., Roh K.H., et al. Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis. Diagn Microbiol Infect Dis 2007, 57:315-318.
20. Song W., Bae I.K., Lee Y.N., Lee C.H., Lee S.H., Jeong S.H. Detection of extended-spectrum beta-lactamases by using boronic acid as an AmpC beta-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli. J Clin Microbiol 2007, 45:1180-1184.
21. Yagi T., Wachino J., Kurokawa H., Suzuki S., Yamane K., Doi Y., et al. Practical methods using boronic acid compounds for identification of class C beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 2005, 43:2551-2558.
22. Perez-Perez F.J., Hanson N.D. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002, 40:2153-2162.
23. Azap O.K., Arslan H., Serefhanoglu K., Colakoglu S., Erdogan H., Timurkaynak F., et al. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin Microbiol Infect 2010, 16:147-151.
24. Wu Y.H., Chen P.L., Hung Y.P., Ko W.C. Risk factors and clinical impact of levofloxacin or cefazolin nonsusceptibility or ESBL production among uropathogens in adults with community-onset urinary tract infections. J Microbiol Immunol Infect 2014, 47:197-203.
25. Schwaber M.J., Klarfeld-Lidji S., Navon-Venezia S., Schwartz D., Leavitt A., Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008, 52:1028-1033.
26. Park Y.S., Yoo S., Seo M.R., Kim J.Y., Cho Y.K., Pai H. Risk factors and clinical features of infections caused by plasmid-mediated AmpC beta-lactamase-producing Enterobacteriaceae. Int J Antimicrob Agents 2009, 34:38-43.
27. Depardieu F., Podglajen I., Leclercq R., Collatz E., Courvalin P. Modes and modulations of antibiotic resistance gene expression. Clin Microbiol Rev 2007, 20:79-114.
28. Wu U.I., Yang C.S., Chen W.C., Chen Y.C., Chang S.C. Risk factors for bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli. J Microbiol Immunol Infect 2010, 43:310-316.
29. Paterson D.L. "Collateral damage" from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis 2004, 38(Suppl. 4):S341-S345.
30. Kaczmarek F.M., Dib-Hajj F., Shang W., Gootz T.D. High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe. Antimicrob Agents Chemother 2006, 50:3396-3406.
31. Yamasaki K., Komatsu M., Abe N., Fukuda S., Miyamoto Y., Higuchi T., et al. Laboratory surveillance for prospective plasmid-mediated AmpC beta-lactamases in the Kinki region of Japan. J Clin Microbiol 2010, 48:3267-3273.
32. Mata C., Miro E., Alvarado A., Garcillan-Barcia M.P., Toleman M., Walsh T.R., et al. Plasmid typing and genetic context of AmpC beta-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes: findings from a Spanish hospital 1999-2007. J Antimicrob Chemother 2012, 67:115-122.
33. Singtohin S., Chanawong A., Lulitanond A., Sribenjalux P., Auncharoen A., Kaewkes W., et al. CMY-2, CMY-8b, and DHA-1 plasmid-mediated AmpC beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from a university hospital, Thailand. Diagn Microbiol Infect Dis 2010, 68:271-277.
34. Lautenbach E., Patel J.B., Bilker W.B., Edelstein P.H., Fishman N.O. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001, 32:1162-1171.
35. Asensio A., Oliver A., Gonzalez-Diego P., Baquero F., Perez-Diaz J.C., Ros P., et al. Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin Infect Dis 2000, 30:55-60.